Clinical trials: Sensorineural Hearing Loss

Sudden Sensorineural Hearing Loss

Oral Statins and Protection From Hearing Loss

• Terminated
• Age: 18 to 80 years
• Phase 4
• Results posted

A small clinical trial for idiopathic sudden sensorineural hearing loss (ISSNHL). Will the addition of an oral statin to the standard treatment (oral methylprednesolone and the salvage therapy of intratympanic dexamethasone)…

Trial name

NCT04826237

Testing

Statin, methylprednisolone, dexamethasone

Where

United States

Volunteers

3 people

Sponsor

Northwestern University